Trial in progress

SYS6010 against chemotherapy after earlier treatment

SYS6010 phase 3 · CSPC · 436 people planned · Registered completion December 2028

Not yet openRegistered completion December 2028

What is being tested

SYS6010, an antibody-drug conjugate, against standard single-drug chemotherapy.

Why it matters

One of six phase 3 trials testing this type of drug as a later treatment.

ClinicalTrials.gov record ↗ ← Back to the outlook
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.